Full-Time

Device Project Management Director

Confirmed live in the last 24 hours

Vertex Pharmaceuticals

Vertex Pharmaceuticals

1,001-5,000 employees

Develops medicines for serious diseases

Compensation Overview

$183.8k - $275.7k/yr

+ Bonus + Equity Awards

Senior, Expert

Company Does Not Provide H1B Sponsorship

Providence, RI, USA

Hybrid-Eligible: work remotely up to two days per week; or work five days per week on-site with ad hoc flexibility.

Category
Project Management
Business & Strategy
Required Skills
Risk Management
Requirements
  • Design Controls in accordance with ISO 13485, EU MDR, FDA Title 21 CFR Part 4, and FDA 21 CFR Part 820.
  • Risk management per ISO 14971 including user, process and design FMEA’s
  • Project management discipline to develop plans, define scope, design controls, DHF management and manage budget/schedule/resources
  • Drive the development and tracking of roadmaps, project schedules, risks/mitigation plans, deliverables, and KPI’s.
  • Communicate program status, program readiness, business and technical issues, risks and their resolution across Engineering, including senior management.
  • Doctorate degree & 4 years of Project Management experience OR Master’s degree & 5 years of Project Management experience OR Bachelor’s degree & 8 years of Project Management experience AND significant experience with project management tools and technology in the healthcare industry.
Responsibilities
  • Lead highly complex, large-scale internal and external new product development programs.
  • Develop detailed schedules, DHF management, define objectives and goals for the different, sub-projects/workstreams, and individual team members.
  • Facilitation of cross-functional team workshops to map current state processes, identify opportunities and define solutions.
  • Proactively lead the team to identify and assess areas of risk, escalate issues in a timely manner, and collaboratively develop thorough contingency, mitigation, and other risk retirement plans.
  • Establish strong working relationships with diverse functional areas to understand cross-functional inputs and interdependencies for combination product development.
  • Effective stakeholder management and change management for buy-in and integration of processes, deliverables, technologies and roles/responsibilities into existing teams and infrastructure.
  • Define and direct budgets for multiple programs including resource loading, external expenses, and capital requirements.
Vertex Pharmaceuticals

Vertex Pharmaceuticals

View

Vertex Pharmaceuticals develops medicines for serious diseases, focusing on conditions like cystic fibrosis. The company conducts extensive research and development to create new drugs, often collaborating with other biotech firms to enhance its therapeutic offerings. One of its notable products is ivacaftor, which has shown effectiveness in treating cystic fibrosis. Vertex differentiates itself from competitors through its commitment to scientific innovation and strategic partnerships that expand its research capabilities. The goal of Vertex Pharmaceuticals is to improve the quality of life for patients with severe and life-threatening conditions by bringing effective treatments to market.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Boston, Massachusetts

Founded

1989

Simplify Jobs

Simplify's Take

What believers are saying

  • EU approval for expanded cystic fibrosis treatment label boosts market penetration in Europe.
  • Partnership with Arbor Biotechnologies positions Vertex at the forefront of innovative treatments.
  • Recent investments indicate strong investor confidence in Vertex's growth potential.

What critics are saying

  • Recent layoffs suggest financial or strategic challenges impacting operational capabilities.
  • Discontinuation of diabetes asset indicates difficulty diversifying beyond cystic fibrosis.
  • Reliance on key products like ivacaftor makes Vertex vulnerable to market fluctuations.

What makes Vertex Pharmaceuticals unique

  • Vertex focuses on transformative medicines for serious diseases, like cystic fibrosis.
  • The company invests heavily in R&D and strategic partnerships for drug development.
  • Vertex's collaboration with Arbor Biotechnologies advances novel ex vivo engineered cell therapies.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Hybrid Work Options

Company News

Pharmalive
Jun 11th, 2025
After axing diabetes asset, Vertex lays off 140 staff

After axing diabetes asset, Vertex lays off 140 staff.

PBN
Jun 10th, 2025
Vertex Pharmaceuticals to lay off 125 R.I. employees

PROVIDENCE - Vertex Pharmaceuticals Inc. is laying off 125 people in Rhode Island, according to a WARN notice filed with the R.I. Department of Labor and Training on June 8.

Buniversity
May 1st, 2025
VERTEX upset Grayhound for spot at BLAST Showdown

VERTEX locked in a first-place finish at Fortress OCE Masters Fall 2022 Finals in Melbourne to qualify for BLAST Premier Fall Showdown.

BioSpace
Apr 14th, 2025
Vertex Researcher, Paul Negulescu Ph.D., Receives the 2025 Canada Gairdner International Award for Pioneering Research and Discovery of Medicines for Cystic Fibrosis

Vertex researcher, Paul Negulescu Ph.D., receives the 2025 Canada Gairdner International Award for pioneering Research and discovery of medicines for Cystic Fibrosis.

Biz Owner Daily
Apr 7th, 2025
EU Approves Expanded Label for Vertex Pharmaceuticals' Cystic Fibrosis Treatment

Vertex Pharmaceuticals has received approval from the European Union to broaden the label for its cystic fibrosis treatment.